{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:28:43Z","timestamp":1758040123066,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ahj.2017.07.015","type":"journal-article","created":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T14:00:20Z","timestamp":1501682420000},"page":"46-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis"],"prefix":"10.1016","volume":"193","author":[{"given":"Juan J.","family":"Russo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun G.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warren J.","family":"Cantor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis T.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Bagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary K.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Di Mario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrun","family":"Halvorsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Le May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Fernandez-Avil\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Scheller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul W.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Borgia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Piscione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro L.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew T.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2017.07.015_bb0005","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.07.015_bb0010","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.07.015_bb0015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jacc.2005.04.042","article-title":"Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study)","volume":"46","author":"Le May","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.07.015_bb0020","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0735-1097(03)00763-0","article-title":"Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction","volume":"42","author":"Scheller","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.07.015_bb0025","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/eurheartj\/ehl088","volume":"27","author":"Armstrong","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.07.015_bb0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jacc.2009.08.007","volume":"55","author":"Bohmer","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.07.015_bb0035","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0140-6736(04)17059-1","article-title":"Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial","volume":"364","author":"Fernandez-Aviles","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.07.015_bb0040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(08)60268-8","article-title":"Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial","volume":"371","author":"Di Mario","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.07.015_bb0045","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1056\/NEJMoa0808276","article-title":"Routine early angioplasty after fibrinolysis for acute myocardial infarction","volume":"360","author":"Cantor","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.07.015_bb0050","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/eurheartj\/ehq204","article-title":"Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis","volume":"31","author":"Borgia","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.07.015_bb0055","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jcin.2011.05.022","article-title":"Characteristics and in-hospital outcomes of patients with non\u2013ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention","volume":"4","author":"Hanna","year":"2011","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.ahj.2017.07.015_bb0060","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/heart.89.9.1003","article-title":"Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE)","volume":"89","author":"Santopinto","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2017.07.015_bb0065","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.107.696765","article-title":"Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction","volume":"116","author":"Herzog","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.07.015_bb0070","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.296.11.1377","article-title":"Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease","volume":"296","author":"Coca","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2017.07.015_bb0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2796.2009.02204.x","article-title":"Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register","volume":"268","author":"Szummer","year":"2010","journal-title":"J Intern Med"},{"key":"10.1016\/j.ahj.2017.07.015_bb0080","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ahj.2014.07.027","article-title":"Routine invasive management early after fibrinolysis: relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials","volume":"168","author":"Bagai","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2017.07.015_bb0085","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2017.07.015_bb0090","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1515\/CCLM.2009.264","article-title":"Estimating glomerular filtration rate","volume":"47","author":"Miller","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ahj.2017.07.015_bb0095","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate.[erratum appears in Ann Intern Med. 2011 Sep 20;155(6):408]","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2017.07.015_bb0100","first-page":"1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","author":"Levin","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ahj.2017.07.015_bb0105","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ahj.2017.07.015_bb0110","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1503\/cmaj.080351","article-title":"Guidelines for the management of chronic kidney disease","volume":"179","author":"Levin","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.ahj.2017.07.015_bb0115","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/eurheartj\/ehr008","volume":"32","author":"Yan","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.07.015_bb0120","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/01.CIR.102.17.2031","article-title":"TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy","volume":"102","author":"Morrow","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.07.015_bb0125","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1161\/CIRCULATIONAHA.105.558676","article-title":"Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty","volume":"112","author":"Thune","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.07.015_bb0130","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/jama.286.11.1356","article-title":"Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3","volume":"286","author":"Morrow","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2017.07.015_bb0135","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0002-9149(03)00716-1","article-title":"Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes","volume":"92","author":"Keeley","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2017.07.015_bb0140","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0735-1097(02)01745-X","article-title":"The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions","volume":"39","author":"Best","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.07.015_bb0145","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/eurheartj\/ehp014","article-title":"Temporal management patterns and outcomes of non\u2013ST elevation acute coronary syndromes in patients with kidney dysfunction","volume":"30","author":"Wong","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.07.015_bb0150","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.07.015_bb0155","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0002-9149(02)02844-8","article-title":"Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial)","volume":"90","author":"Januzzi","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2017.07.015_bb0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcin.2008.09.010","article-title":"Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events)","volume":"2","author":"Medi","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.ahj.2017.07.015_bb0165","doi-asserted-by":"crossref","first-page":"06","DOI":"10.1161\/JAHA.116.004113","article-title":"Temporal trends in care and outcomes of patients receiving fibrinolytic therapy compared to primary percutaneous coronary intervention: insights from the Get With The Guidelines Coronary Artery Disease (GWTG-CAD) registry","volume":"5","author":"Hira","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2017.07.015_bb0170","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.jcin.2016.08.004","article-title":"The choice is reperfusion therapy: but which one?","volume":"9","author":"Henry","year":"2016","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.ahj.2017.07.015_bb0175","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jacc.2003.06.001","article-title":"Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality","volume":"42","author":"Gibson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.07.015_bb0180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/B:THRO.0000024055.13207.50","article-title":"The prognostic value of serum creatinine on admission in fibrinolytic-eligible patients with acute myocardial infarction","volume":"16","author":"Hobbach","year":"2003","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ahj.2017.07.015_bb0185","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1136\/hrt.2009.188243","article-title":"RIKS-HIA registry. Fibrinolytic therapy and bleeding complications: risk predictors from RIKS-HIA","volume":"96","author":"Oldgren","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2017.07.015_bb0190","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.jacc.2011.06.050","article-title":"Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care?","volume":"58","author":"Motivala","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.07.015_bb0195","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.jacc.2011.07.028","article-title":"The end of the risk-treatment paradox? A rising tide lifts all boats","volume":"58","author":"McAlister","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.07.015_bb0200","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCOUTCOMES.109.858456","article-title":"Determinants of cardiac catheterization use in older medicare patients with acute myocardial infarction","volume":"3","author":"Ko","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317302156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317302156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:59:29Z","timestamp":1757570369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870317302156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":40,"alternative-id":["S0002870317302156"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2017.07.015","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2017.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}